• Tesla stock is now fully tradable on-chain via a decentralized exchange, offering 24/7 access without traditional market restrictions.
  • Injective continues expanding with institutional collaborations, including Deutsche Telekom MMS as a validator and Libre’s integration for institutional fund access.

The stock market and the crypto space are becoming more interconnected. Just posted on its mainnet, Injective announced that Tesla (TSLA) stock is now accessible for on-chain trading. Previously exclusively available on the Solstice testnet, this feature is now available on the mainnet of Injective, therefore enabling complete Tesla stock trading capability.

For investors who wish to trade stocks in a decentralized way free from traditional trading hours, this decision creates new opportunities. Wait no more for the market to close in the afternoon or open in the morning. Using Injective’s blockchain technology, one has more flexible, open, 24/7 access to Tesla stock.

$TSLA is now live on Injective.

You saw it on the Solstice testnet, now experience Tesla on mainnet for the first time.

Fully onchain stocks with 24/7 access and endless opportunities. Only possible on Injective. https://t.co/wpEnUmElUj

— Injective 🥷 (@injective) March 18, 2025

Injective Expands On-Chain Stock Offerings Beyond Tesla

Tesla is not the first stock to enter the Injective ecosystem. On March 14, as we previously reported , Injective launched a new iAsset enabling on-chain trading of Robinhood (HOOD) stock. Users of this feature can trade Robinhood stock at any moment with more liquidity than on traditional stock markets.

These benefits make Injective even more appealing to investors seeking new approaches to trading financial products.

Furthermore, Injective provides a governance proposal aiming at including McDonald’s stock perpetual contracts into the dApps ecosystem of her network. By means of its governance approach, the platform seeks to include McDonald’s shares in the on-chain environment, therefore extending the scope of the decentralized financial market.

Moreover, on February 10, Injective started an on-chain index tracking hundreds of the biggest public stocks via a single unified index. Investors with this index get unrestricted access to the stock market without having to pass middlemen that may slow down the transaction process.

Cooperation amongst Big Players

Big corporations are helping the injective ecosystem to get stronger. Officially joining as a validator on the Injective blockchain was Deutsche Telekom MMS, a division of Deutsche Telekom. This move is a genuine attempt to improve the security and decentralization of the network as well as a mere name addition.

Through on-chain governance and transaction validation, Injective shows even more how blockchain technology may coexist peacefully with traditional financial institutions.

On the other hand, on March 4, Injective partnered with Libre, a digital infrastructure platform granting access to accredited and institutional investors.

By means of this integration, Injective gains the institutional fund issuing and distribution platform, thereby enabling big investors to access a range of on-chain investment funds, including the just announced BlackRock Money Market Fund. Stated differently, injective attracts not only retail traders but also heavyweight investors more and more.

Meanwhile, as of the writing time, INJ is swapped hands at about $9.94, up 3.25% over the last 24 hours and 6.09% over the last 7 days.